Please login to the form below

Not currently logged in
Email:
Password:

InnoPharma appoints Deborah DuFresne as VP

Will head strategic portfolio selection and management

Deborah DuFresne has joined InnoPharma as VP, strategic portfolio selection and management.

She joins the US-based company from Impax Laboratories where she was senior director, project management, product identification and development.

DuFresne has also held senior roles at Fera Pharmaceuticals, Sandoz and Apotex.

"Deborah's broad generic and specialty pharmaceutical experience and extensive product knowledge will be vital to InnoPharma as we seek to enhanc our portfolio in a strategic manner,” said InnoPharma's president and CEO Dr Navneet Puri.

“We look forward to working with Deborah as we continue to build our business and execute on our goals."

13th August 2013

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....